Systematic Review Tracks Gut Microbiome Changes Across Aging and Longevity
The article discusses a systematic review of human studies examining how gut microbial populations differ among younger adults, older adults, and exceptionally long-lived people such as centenarians. According to the review, aging is associated with a rise in inflammation-promoting microbes and a decline in those that produce beneficial metabolites, with shifts detectable from around the mid-30s. The piece notes that future therapies might deliberately reshape the microbiome to counter aging, though current options like probiotics are temporary and fecal transplants lack precise control.
The review examined 41 eligible human studies, some involving centenarians, and compared microbial patterns across age groups. In 2023, gut microbiome dysbiosis was added to the hallmarks of aging framework; it involves lower microbial diversity and more inflammation-linked species.
Age-related microbial shifts may begin around the mid-30s and vary with health, diet, lifestyle, medications, and cohort. Later life often shows a less balanced community, reduced beneficial metabolite output, and disrupted immune function. Current interventions remain limited: probiotics offer temporary changes, while fecal transplants can be lasting but imprecise.
This review may shape how researchers, clinicians, and older adults think about aging and gut health. If microbial signatures become reliable, they could inform diet, probiotic, or transplant strategies, potentially benefiting people at risk of age-related disease. However, because current interventions are temporary or imprecise, near-term societal effects may be modest and mainly felt in research, wellness marketing, and clinical counseling. Long-term impact depends on validating findings across diverse populations.